Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-25

FDA Approved: EVKEEZA — Supplemental Application (Regeneron Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EVKEEZA (evinacumab) from Regeneron Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evkeeza (evinacumab)

Snippet

SUPPL AP for EVKEEZA (EVINACUMAB)